Delivery Order SPE2DB22D1052-SPE2DB25FU9QE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,393.96 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $16,287.19 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product for anticoagulation therapy. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,669.21 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. The contract is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive, non-set-aside award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $22,144.15 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product commonly used for anticoagulation therapy. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $11,944.06 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. Awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside delivery order. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,929.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9QEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,295.46 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract running through December 2026 that serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. The parent contract enables AmerisourceBergen to supply a broad spectrum of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. This specific delivery order represents one transaction within the extensive pharmaceutical distribution services provided through this strategic agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/22/25 |